FDA Import Refusal 799-1082414-6/40003/1 — Merck Limited
The FDA refused shipment 799-1082414-6/40003/1 from Merck Limited (India) on Jan 12, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 12, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 118,75